|
FACS
Fluvastatin in the therapy of Acute Coronary Syndrome
Ongoing trial
 |
Author(s) |
Ostadal P, Alan D, Hajek P, Vejvoda J, Mates M, Blasko P, Veselka J, Kvapil M, Kettner J, Wiendl M, Aschermann O, Slaby J, Nemecek E, Holm F, Rac M, Macek M, Cepova J |
 |
Title(s) |
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696] |
|
Reference(s) |
Curr Control Trials Cardiovasc Med 2005;6:4 |
|
Disease |
Acute coronary syndromes |
|
Purpose |
To assess the effects of early administration of fluvastatin in patients with acute coronary syndromes |
|
Study design |
Randomised, double-blind, placebo-controlled |
|
Follow-up |
Aim 30 days |
|
Patients |
Aim 1000 patients, aged ≥ 18 years, hospitalised for acute coronary syndromes with or without ST elevation |
|
Treatment regimen |
Fluvastatin, 80 mg/day, or placebo |
|
Results |
Not yet available |
|
|
|
